BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17715336)

  • 1. Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease.
    Heng MY; Tallaksen-Greene SJ; Detloff PJ; Albin RL
    J Neurosci; 2007 Aug; 27(34):8989-98. PubMed ID: 17715336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.
    Lloret A; Dragileva E; Teed A; Espinola J; Fossale E; Gillis T; Lopez E; Myers RH; MacDonald ME; Wheeler VC
    Hum Mol Genet; 2006 Jun; 15(12):2015-24. PubMed ID: 16687439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel BAC Mouse Model of Huntington's Disease with 225 CAG Repeats Exhibits an Early Widespread and Stable Degenerative Phenotype.
    Wegrzynowicz M; Bichell TJ; Soares BD; Loth MK; McGlothan JS; Mori S; Alikhan FS; Hua K; Coughlin JM; Holt HK; Jetter CS; Pomper MG; Osmand AP; Guilarte TR; Bowman AB
    J Huntingtons Dis; 2015; 4(1):17-36. PubMed ID: 26333255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.
    Menalled LB; Sison JD; Wu Y; Olivieri M; Li XJ; Li H; Zeitlin S; Chesselet MF
    J Neurosci; 2002 Sep; 22(18):8266-76. PubMed ID: 12223581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex differences in behavior and striatal ascorbate release in the 140 CAG knock-in mouse model of Huntington's disease.
    Dorner JL; Miller BR; Barton SJ; Brock TJ; Rebec GV
    Behav Brain Res; 2007 Mar; 178(1):90-7. PubMed ID: 17239451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal behavioral, cross-sectional transcriptional and histopathological characterization of a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Rising AC; Xu J; Carlson A; Napoli VV; Denovan-Wright EM; Mandel RJ
    Exp Neurol; 2011 Apr; 228(2):173-82. PubMed ID: 21192926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF
    J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological abnormalities in a knock-in mouse model of Huntington's disease.
    Lin CH; Tallaksen-Greene S; Chien WM; Cearley JA; Jackson WS; Crouse AB; Ren S; Li XJ; Albin RL; Detloff PJ
    Hum Mol Genet; 2001 Jan; 10(2):137-44. PubMed ID: 11152661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of the behavioural phenotype in Hdh(CAG)150 Huntington's disease knock-in mice.
    Brooks S; Higgs G; Jones L; Dunnett SB
    Brain Res Bull; 2012 Jun; 88(2-3):182-8. PubMed ID: 20457230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early onset deficits on the delayed alternation task in the Hdh(Q92) knock-in mouse model of Huntington's disease.
    Trueman RC; Jones L; Dunnett SB; Brooks SP
    Brain Res Bull; 2012 Jun; 88(2-3):156-62. PubMed ID: 21440047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice.
    Wheeler VC; Gutekunst CA; Vrbanac V; Lebel LA; Schilling G; Hersch S; Friedlander RM; Gusella JF; Vonsattel JP; Borchelt DR; MacDonald ME
    Hum Mol Genet; 2002 Mar; 11(6):633-40. PubMed ID: 11912178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease.
    Brustovetsky N; LaFrance R; Purl KJ; Brustovetsky T; Keene CD; Low WC; Dubinsky JM
    J Neurochem; 2005 Jun; 93(6):1361-70. PubMed ID: 15935052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.
    Hölter SM; Stromberg M; Kovalenko M; Garrett L; Glasl L; Lopez E; Guide J; Götz A; Hans W; Becker L; Rathkolb B; Rozman J; Schrewed A; Klingenspor M; Klopstock T; Schulz H; Wolf E; Wursta W; Gillis T; Wakimoto H; Seidman J; MacDonald ME; Cotman S; Gailus-Durner V; Fuchs H; de Angelis MH; Lee JM; Wheeler VC
    PLoS One; 2013; 8(11):e80923. PubMed ID: 24278347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum.
    Wheeler VC; Lebel LA; Vrbanac V; Teed A; te Riele H; MacDonald ME
    Hum Mol Genet; 2003 Feb; 12(3):273-81. PubMed ID: 12554681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal atrophy and dendritic alterations in a knock-in mouse model of Huntington's disease.
    Lerner RP; Trejo Martinez Ldel C; Zhu C; Chesselet MF; Hickey MA
    Brain Res Bull; 2012 Apr; 87(6):571-8. PubMed ID: 22326483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.
    Yhnell E; Dunnett SB; Brooks SP
    J Huntingtons Dis; 2016 May; 5(2):149-61. PubMed ID: 27258586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p75 neurotrophin receptor augments survival signaling in the striatum of pre-symptomatic Q175(WT/HD) mice.
    Wehner AB; Milen AM; Albin RL; Pierchala BA
    Neuroscience; 2016 Jun; 324():297-306. PubMed ID: 26947127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.